Related Experiment Video
Updated: Oct 15, 2025

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
Oscillospira - a candidate for the next-generation probiotics
Jingpeng Yang1, Yanan Li1, Zhiqiang Wen1
1School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.
Oscillospira, found in animal and human guts, is linked to obesity and other health conditions. This organism shows potential as a next-generation probiotic due to its production of beneficial short-chain fatty acids.
Area of Science:
- Microbiology
- Human Gut Microbiome Research
- Probiotics
Background:
- Oscillospira is a gut microbe detected via high-throughput sequencing, not yet pure-cultured.
- Its abundance correlates with obesity, leanness, and overall human health.
- Emerging research links Oscillospira to gallstones and chronic constipation.
Purpose of the Study:
- To explore the role of Oscillospira in human health and disease.
- To investigate Oscillospira's potential as a next-generation probiotic.
Main Methods:
- Analysis of high-throughput sequencing data.
- Metabolic profiling of gut contents.
Main Results:
- Oscillospira is prevalent in animal and human intestines.
- Variations in Oscillospira abundance are associated with obesity and leanness.
- Sequencing and metabolic data suggest Oscillospira produces short-chain fatty acids (SCFAs), like butyrate.
Conclusions:
- Oscillospira is a promising candidate for next-generation probiotics.
- Its potential applications span the food, healthcare, and biopharmaceutical industries.
- Further research into Oscillospira could yield novel health interventions.
More Related Videos
Related Concept Videos
Bacterial Phylum Spirochaetes
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Other Unique Bacteria
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Bacterial Phylum Firmicutes
Bacterial Phylum Tenericutes

